I personally would like to know a bit more information regarding the Sigma investment... we're still sitting on the investment, which feels a bit like the fence at this point.
It would be a good acquisition at the right price, but if that's not the plan I'm not 100% sure we should continue to hold, that has attributed to current debt levels... I may be off with my assumption, does anyone know any better or differ in thought?
- Forums
- ASX - By Stock
- API
- News: API Australian Pharmaceutical Industries Posts FY NPAT Of $56.6 Mln
News: API Australian Pharmaceutical Industries Posts FY NPAT Of $56.6 Mln, page-9
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)